American Century Companies’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $200K | Buy |
69,285
+5,001
| +8% | +$14.5K | ﹤0.01% | 2736 |
|
2025
Q1 | $138K | Buy |
64,284
+7,990
| +14% | +$17.2K | ﹤0.01% | 2802 |
|
2024
Q4 | $218K | Buy |
56,294
+13,891
| +33% | +$53.8K | ﹤0.01% | 2768 |
|
2024
Q3 | $278K | Buy |
42,403
+26,600
| +168% | +$174K | ﹤0.01% | 2673 |
|
2024
Q2 | $115K | Sell |
15,803
-29,833
| -65% | -$216K | ﹤0.01% | 2800 |
|
2024
Q1 | $346K | Buy |
45,636
+34,120
| +296% | +$259K | ﹤0.01% | 2582 |
|
2023
Q4 | $52.4K | Sell |
11,516
-130
| -1% | -$592 | ﹤0.01% | 2844 |
|
2023
Q3 | $46K | Buy |
+11,646
| New | +$46K | ﹤0.01% | 2812 |
|